Managing Insulin With a Voice AI

Trial ID or NCT#



not recruiting iconNOT RECRUITING


This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.

Official Title

Using an AI-based Voice Assistant to Manage Insulin in Diabetes: a Randomized-Control Trial

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - Patients with Type 2 Diabetes - Patients clinically indicated to be taking daily long-acting insulin - Patients currently taking long-acting insulin but necessitating active dose adjustments
Exclusion Criteria:
  1. - Patients who do not speak English - Patients who do not own a smart phone - Patients who do not have stable wireless internet connection at home


Kevin Schulman
Professor of Medicine (Hospital Medicine), by courtesy, of Health Policy and of Operations, Information and Technology at the Graduate School of Business
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Sharif Vakili, MD, MBA, MS
Sharif Vakili, MD, MBA, MS
Internal medicine doctor
Clinical Assistant Professor, Medicine - Primary Care and Population Health

Contact us to find out if this trial is right for you.


Study Team